Agneta Ohlsson

587 total citations
8 papers, 434 citations indexed

About

Agneta Ohlsson is a scholar working on Pharmacology, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Agneta Ohlsson has authored 8 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Clinical Psychology and 2 papers in Molecular Biology. Recurrent topics in Agneta Ohlsson's work include Cannabis and Cannabinoid Research (4 papers), Psychedelics and Drug Studies (3 papers) and Forensic Toxicology and Drug Analysis (2 papers). Agneta Ohlsson is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Psychedelics and Drug Studies (3 papers) and Forensic Toxicology and Drug Analysis (2 papers). Agneta Ohlsson collaborates with scholars based in Sweden, United States and Germany. Agneta Ohlsson's co-authors include Stig Agurell, Jan‐Erik Lindgren, Leo E. Hollister, Hampton Gillespie, H. K. Gillespie, A. Wahlén, Hansruedi Glatt, Franz Oesch, David Jones and William L. Dewey and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Chromatography A and Psychopharmacology.

In The Last Decade

Agneta Ohlsson

7 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agneta Ohlsson Sweden	7	359	134	116	64	54	8	434
M Widman Sweden	14	520 1.4×	227 1.7×	178 1.5×	131 2.0×	62 1.1×	31	739
Eva Johansson Sweden	9	275 0.8×	71 0.5×	145 1.3×	81 1.3×	27 0.5×	13	384
Kenneth H. Davis United States	13	525 1.5×	225 1.7×	215 1.9×	104 1.6×	41 0.8×	21	732
Gene Barnett United States	14	235 0.7×	162 1.2×	156 1.3×	31 0.5×	25 0.5×	21	559
Ross E. Crabtree United States	13	260 0.7×	119 0.9×	50 0.4×	31 0.5×	102 1.9×	24	554
Leo F. Englert United States	11	243 0.7×	204 1.5×	59 0.5×	18 0.3×	32 0.6×	16	377
A.V. Daza United States	12	244 0.7×	170 1.3×	93 0.8×	79 1.2×	32 0.6×	22	658
Thomas Nadulski Germany	11	381 1.1×	165 1.2×	265 2.3×	162 2.5×	76 1.4×	18	632
George M. Milne United States	12	622 1.7×	416 3.1×	185 1.6×	39 0.6×	40 0.7×	17	747
R. I. Freudenthal United States	9	191 0.5×	98 0.7×	54 0.5×	40 0.6×	39 0.7×	21	354

Countries citing papers authored by Agneta Ohlsson

Since Specialization

Citations

This map shows the geographic impact of Agneta Ohlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Ohlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Ohlsson more than expected).

Fields of papers citing papers by Agneta Ohlsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta Ohlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Ohlsson. The network helps show where Agneta Ohlsson may publish in the future.

Co-authorship network of co-authors of Agneta Ohlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta Ohlsson. A scholar is included among the top collaborators of Agneta Ohlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta Ohlsson. Agneta Ohlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ohlsson, Agneta, et al.. (2012). A regulatory approach to assess the potency of substances toxic to the reproduction. Regulatory Toxicology and Pharmacology. 63(1). 97–105. 1 indexed citations

2.

Halldin, Magnus M., et al.. (1992). Synthesis of a labelled terpene synthon, useful in the preparation of metabolites of Δ¹‐tetrahydrocannabinol. Journal of Labelled Compounds and Radiopharmaceuticals. 31(2). 131–142. 6 indexed citations

3.

Ohlsson, Agneta, et al.. (1986). Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Journal of Mass Spectrometry. 13(2). 77–83. 181 indexed citations

4.

Ohlsson, Agneta, et al.. (1982). Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.. Journal of Pharmacology and Experimental Therapeutics. 221(2). 362–367. 15 indexed citations

5.

Ohlsson, Agneta, Jan‐Erik Lindgren, A. Wahlén, et al.. (1982). Single dose kinetics of deuterium labelled Δ1-tetrahydrocannabinol in heavy and light cannabis users. Journal of Mass Spectrometry. 9(1). 6–10. 78 indexed citations

6.

Lindgren, Jan‐Erik, Agneta Ohlsson, Stig Agurell, Leo E. Hollister, & H. K. Gillespie. (1981). Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis. Psychopharmacology. 74(3). 208–212. 124 indexed citations

7.

Glatt, Hansruedi, Agneta Ohlsson, Stig Agurell, & Franz Oesch. (1979). Δ1-Tetrahydrocannabinol and 1α,2α-epoxyhexahydrocannabinol: Mutagenicity investigation in the ames test. Mutation Research/Genetic Toxicology. 66(4). 329–335. 16 indexed citations

8.

Agurell, Stig & Agneta Ohlsson. (1971). Gas chromatography of ergot alkaloids. Journal of Chromatography A. 61(2). 339–342. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact